Key result
Once-daily enoxaparin cuts thrombosis ~43% vs twice-daily in elderly femur fracture patients.
Why the study?
Does enoxaparin 40 mg once daily prevent distal and proximal thrombosis in elderly patients with a fracture of the neck of the femur compared to enoxaparin 20 mg twice daily?
RCT (n=103)
Double-blind
randomized
Does enoxaparin 40 mg once daily prevent distal and proximal thrombosis in elderly patients with a fracture of the neck of the femur compared to enoxaparin 20 mg twice daily?
A once-daily 40 mg dose of enoxaparin is effective and safe for deep vein thrombosis prophylaxis in elderly patients surgically treated for femoral neck fractures.
Answers are grounded in this paper and cite their sources.
Supports 40 mg once-daily enoxaparin for DVT prophylaxis in elderly femoral neck fracture patients; extends RCT evidence for regimen optimization in orthopedic trauma.
A randomized double-blind study comparing the efficacy and safety of two different dosage regimens of a low-MW heparin, Enoxaparin (Lovenox) 20 mg twice (group A) or 40 mg once (group B), was carried out in 103 elderly patients with a fracture of the neck of the femur. Distal and proximal thrombosis occurred in 18.3% of patients in group A and in 10.4% in group B. No major hemorrhagic complication was observed, except for two hematomas in each group. This trial suggests that a total daily dose of 40 mg of Enoxaparin can be effective in the prevention of deep vein thrombosis in elderly surgically treated patients and does not involve a major risk of bleeding.
No takes yet. Share an insight, caveat, or question.
Barsotti et al. (1990) conducted an RCT in Fracture of the neck of the femur (n=103). Enoxaparin vs. Enoxaparin 20 mg twice daily was evaluated on Distal and proximal thrombosis. Enoxaparin once daily resulted in a 10.4% rate of distal and proximal thrombosis compared to 18.3% with twice daily in elderly patients with femur neck fractures.
Synapse has enriched 10 related papers. Consider them for comparative context: